• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核苷酸与具有抗病毒活性的无环核苷膦酸酯的配位化学,包括机理考量

Coordination Chemistry of Nucleotides and Antivirally Active Acyclic Nucleoside Phosphonates, including Mechanistic Considerations.

作者信息

Sigel Astrid, Sigel Helmut, Sigel Roland K O

机构信息

Department of Chemistry, University of Basel, St. Johannsring 19, CH-4056 Basel, Switzerland.

Department of Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

出版信息

Molecules. 2022 Apr 19;27(9):2625. doi: 10.3390/molecules27092625.

DOI:10.3390/molecules27092625
PMID:35565975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9103026/
Abstract

Considering that practically all reactions that involve nucleotides also involve metal ions, it is evident that the coordination chemistry of nucleotides and their derivatives is an essential corner stone of biological inorganic chemistry. Nucleotides are either directly or indirectly involved in all processes occurring in Nature. It is therefore no surprise that the constituents of nucleotides have been chemically altered-that is, at the nucleobase residue, the sugar moiety, and also at the phosphate group, often with the aim of discovering medically useful compounds. Among such derivatives are acyclic nucleoside phosphonates (ANPs), where the sugar moiety has been replaced by an aliphatic chain (often also containing an ether oxygen atom) and the phosphate group has been replaced by a phosphonate carrying a carbon-phosphorus bond to make the compounds less hydrolysis-sensitive. Several of these ANPs show antiviral activity, and some of them are nowadays used as drugs. The antiviral activity results from the incorporation of the ANPs into the growing nucleic acid chain-i.e., polymerases accept the ANPs as substrates, leading to chain termination because of the missing 3'-hydroxyl group. We have tried in this review to describe the coordination chemistry (mainly) of the adenine nucleotides AMP and ATP and whenever possible to compare it with that of the dianion of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA = adenine(N9)-CH-CH-O-CH-PO32) [or its diphosphate (PMEApp)] as a representative of the ANPs. Why is PMEApp a better substrate for polymerases than ATP? There are three reasons: (i) PMEA with its -like conformation (like AMP) fits well into the active site of the enzyme. (ii) The phosphonate group has an enhanced metal ion affinity because of its increased basicity. (iii) The ether oxygen forms a 5-membered chelate with the neighboring phosphonate and favors thus coordination at the P group. Research on ANPs containing a purine residue revealed that the kind and position of the substituent at C2 or C6 has a significant influence on the biological activity. For example, the shift of the (C6)NH group in PMEA to the C2 position leads to 9-[2-(phosphonomethoxy)ethyl]-2-aminopurine (PME2AP), an isomer with only a moderate antiviral activity. Removal of (C6)NH favors N7 coordination, e.g., of Cu, whereas the ether O atom binding of Cu in PMEA facilitates N3 coordination via adjacent 5- and 7-membered chelates, giving rise to a Cu(PMEA) isomer. If the metal ions (M) are M(α,β)-M(γ)-coordinated at a triphosphate chain, transphosphorylation occurs (kinases, etc.), whereas metal ion binding in a M(α)-M(β,γ)-type fashion is relevant for polymerases. It may be noted that with diphosphorylated PMEA, (PMEApp), the M(α)-M(β,γ) binding is favored because of the formation of the 5-membered chelate involving the ether O atom (see above). The self-association tendency of purines leads to the formation of dimeric M(ATP) stacks, which occur in low concentration and where one half of the molecule undergoes the dephosphorylation reaction and the other half stabilizes the structure-i.e., acts as the "enzyme" by bridging the two ATPs. In accord herewith, one may enhance the reaction rate by adding AMP to the Cu(ATP) solution, as this leads to the formation of mixed stacked Cu(ATP)(AMP)(OH) species, in which AMP takes over the structuring role, while the other "half" of the molecule undergoes dephosphorylation. It may be added that Cu(ATP)(PMEA) or better Cu(ATP)(PMEA)(OH) is even a more reactive species than Cu(ATP)(AMP)(OH). - The matrix-assisted self-association and its significance for cell organelles with high ATP concentrations is summarized and discussed, as is, e.g., the effect of tryptophanate (Trp), which leads to the formation of intramolecular stacks in M(ATP)(Trp) complexes (formation degree about 75%). Furthermore, it is well-known that in the active-site cavities of enzymes the dielectric constant, compared with bulk water, is reduced; therefore, we have summarized and discussed the effect of a change in solvent polarity on the stability and structure of binary and ternary complexes: Opposite effects on charged O sites and neutral N sites are observed, and this leads to interesting insights.

摘要

鉴于几乎所有涉及核苷酸的反应也都涉及金属离子,显然核苷酸及其衍生物的配位化学是生物无机化学的重要基石。核苷酸直接或间接地参与自然界中发生的所有过程。因此,核苷酸的组成部分发生化学改变也就不足为奇了——也就是说,在核碱基残基、糖部分以及磷酸基团处都发生了改变,其目的通常是发现具有医学用途的化合物。这类衍生物包括无环核苷膦酸酯(ANP),其中糖部分被脂肪族链(通常还含有一个醚氧原子)取代,磷酸基团被带有碳 - 磷键的膦酸酯取代,以使化合物对水解不那么敏感。其中几种ANP具有抗病毒活性,如今有些已用作药物。抗病毒活性源于ANP掺入正在生长的核酸链中——即聚合酶将ANP作为底物接受,由于缺少3'-羟基而导致链终止。在本综述中,我们试图描述腺嘌呤核苷酸AMP和ATP的配位化学(主要是),并尽可能将其与9 - [2 - (膦酰甲氧基)乙基]腺嘌呤(PMEA = 腺嘌呤(N9) - CH - CH - O - CH - PO32)[或其二磷酸酯(PMEApp)]的二价阴离子的配位化学进行比较,PMEApp作为ANP的代表。为什么PMEApp比ATP更适合作为聚合酶的底物呢?有三个原因:(i)具有类似AMP构象的PMEA能很好地契合酶的活性位点。(ii)膦酸酯基团由于碱性增强而具有更高的金属离子亲和力。(iii)醚氧与相邻的膦酸酯形成一个五元螯合物,从而有利于在磷原子处配位。对含有嘌呤残基的ANP的研究表明,C2或C6处取代基的种类和位置对生物活性有显著影响。例如,PMEA中(C6)NH基团迁移到C2位置会生成9 - [2 - (膦酰甲氧基)乙基] - 2 - 氨基嘌呤(PME2AP),这是一种抗病毒活性中等的异构体。去除(C6)NH有利于N7配位,例如与铜的配位,而PMEA中铜与醚氧原子的结合通过相邻的五元环和七元环螯合物促进N3配位,从而产生一种Cu(PMEA)异构体。如果金属离子(M)以M(α,β) - M(γ)的方式配位在三磷酸链上,就会发生转磷酸化反应(激酶等),而以M(α) - M(β,γ)类型的方式结合金属离子则与聚合酶相关。可以注意到,对于二磷酸化的PMEA(PMEApp),由于形成了涉及醚氧原子的五元螯合物(见上文),M(α) - M(β,γ)结合更受青睐。嘌呤的自缔合倾向导致形成二聚体[M(ATP)](OH)堆积物,这种堆积物在低浓度下出现,其中分子的一半发生去磷酸化反应,另一半稳定结构——即通过桥接两个ATP起到“酶”的作用。与此一致的是,可以通过向[Cu(ATP)](OH)溶液中添加AMP来提高反应速率,因为这会导致形成混合堆积的Cu(ATP)(AMP)(OH)物种,其中AMP承担结构构建的角色,而分子的另“一半”发生去磷酸化反应。还可以补充的是,Cu(ATP)(PMEA)或者更好的Cu(ATP)(PMEA)(OH)甚至比Cu(ATP)(AMP)(OH)更具反应活性。——总结并讨论了基质辅助的自缔合及其对具有高ATP浓度的细胞器的意义,例如色氨酸盐(Trp)的影响,它会导致在M(ATP)(Trp)络合物中形成分子内堆积物(形成程度约为75%)。此外,众所周知,在酶的活性位点腔中,与大量水相比,介电常数降低;因此,我们总结并讨论了溶剂极性变化对二元和三元络合物稳定性和结构的影响:观察到对带电荷的氧位点和中性氮位点有相反的影响,这带来了有趣的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/21ca7b2f0b10/molecules-27-02625-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/e3b6f106d6ac/molecules-27-02625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/c64dcfe7c6cc/molecules-27-02625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/45bf1e7d0228/molecules-27-02625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/2f4d8593e88e/molecules-27-02625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/4ca4c19f2be2/molecules-27-02625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/b9b1137aca3a/molecules-27-02625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/d8f5f1b349e3/molecules-27-02625-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/ba53ad8babf8/molecules-27-02625-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/52758e95b663/molecules-27-02625-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/b78dca2be5a3/molecules-27-02625-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/9cd777b8b6d5/molecules-27-02625-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/6ddbfffd0a3d/molecules-27-02625-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/68bec3bea3dc/molecules-27-02625-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/f799f4f6708b/molecules-27-02625-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/365eb234b4d9/molecules-27-02625-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/18e7fc9a3306/molecules-27-02625-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/78e4d1d77cdb/molecules-27-02625-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/5bfbb75f13fe/molecules-27-02625-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/b8afb8791b9f/molecules-27-02625-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/54535f7180e9/molecules-27-02625-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/21ca7b2f0b10/molecules-27-02625-g021.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/e3b6f106d6ac/molecules-27-02625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/c64dcfe7c6cc/molecules-27-02625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/45bf1e7d0228/molecules-27-02625-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/2f4d8593e88e/molecules-27-02625-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/4ca4c19f2be2/molecules-27-02625-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/b9b1137aca3a/molecules-27-02625-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/d8f5f1b349e3/molecules-27-02625-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/ba53ad8babf8/molecules-27-02625-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/52758e95b663/molecules-27-02625-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/b78dca2be5a3/molecules-27-02625-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/9cd777b8b6d5/molecules-27-02625-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/6ddbfffd0a3d/molecules-27-02625-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/68bec3bea3dc/molecules-27-02625-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/f799f4f6708b/molecules-27-02625-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/365eb234b4d9/molecules-27-02625-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/18e7fc9a3306/molecules-27-02625-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/78e4d1d77cdb/molecules-27-02625-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/5bfbb75f13fe/molecules-27-02625-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/b8afb8791b9f/molecules-27-02625-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/54535f7180e9/molecules-27-02625-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/088f/9103026/21ca7b2f0b10/molecules-27-02625-g021.jpg

相似文献

1
Coordination Chemistry of Nucleotides and Antivirally Active Acyclic Nucleoside Phosphonates, including Mechanistic Considerations.核苷酸与具有抗病毒活性的无环核苷膦酸酯的配位化学,包括机理考量
Molecules. 2022 Apr 19;27(9):2625. doi: 10.3390/molecules27092625.
2
Extent of intramolecular π-stacks in aqueous solution in mixed-ligand copper(II) complexes formed by heteroaromatic amines and several 2-aminopurine derivatives of the antivirally active nucleotide analog 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).在由杂环胺和几种抗病毒活性核苷酸类似物 9-[2-(膦酸甲氧基)乙基]腺嘌呤(PMEA)的 2-氨基嘌呤衍生物形成的混合配体铜(II)配合物的水溶液中,分子内π-堆积的程度。
Chem Biodivers. 2012 Sep;9(9):2008-34. doi: 10.1002/cbdv.201200022.
3
Quantification of isomeric equilibria formed by metal ion complexes of 8-[2-(phosphonomethoxy)ethyl]-8-azaadenine (8,8aPMEA) and 9-[2-(phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA). Derivatives of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA).8-[2-(膦酰甲氧基)乙基]-8-氮杂腺嘌呤(8,8aPMEA)和9-[2-(膦酰甲氧基)乙基]-8-氮杂腺嘌呤(9,8aPMEA)的金属离子络合物形成的异构体平衡的定量分析。抗病毒核苷酸类似物9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA)的衍生物。
J Biol Inorg Chem. 2004 Dec;9(8):961-72. doi: 10.1007/s00775-004-0591-7. Epub 2004 Oct 20.
4
Metal ion-binding properties of 9-[(2-phosphonomethoxy)ethyl]-2-aminopurine (PME2AP), an isomer of the antiviral nucleotide analogue 9-[(2-phosphonomethoxy)ethyl]adenine (PMEA). Steric guiding of metal ion-coordination by the purine-amino group.金属离子结合特性的 9-[(2-膦酸甲氧基)乙基]-2-氨基嘌呤(PME2AP),抗病毒核苷酸类似物 9-[(2-膦酸甲氧基)乙基]腺嘌呤(PMEA)的异构体。嘌呤-氨基基团对金属离子配位的空间引导。
Dalton Trans. 2010 Jul 21;39(27):6344-54. doi: 10.1039/c005238h. Epub 2010 Jun 3.
5
Formation of ternary complexes by coordination of (diethylenetriamine)-platinum(II) to N1 or N7 of the adenine moiety of the antiviral nucleotide analogue 9.通过(二亚乙基三胺)-铂(II)与抗病毒核苷酸类似物9的腺嘌呤部分的N1或N7配位形成三元复合物。
Chemistry. 2001 May 4;7(9):1899-908. doi: 10.1002/1521-3765(20010504)7:9<1899::aid-chem1899>3.0.co;2-5.
6
Acid-base and metal-ion-binding properties of 9-[2-(2-phosphonoethoxy)ethyl]adenine (PEEA), a relative of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA). An exercise on the quantification of isomeric complex equilibria in solution.9-[2-(2-膦酰基乙氧基)乙基]腺嘌呤(PEEA)的酸碱和金属离子结合特性,它是抗病毒核苷酸类似物9-[2-(膦酰基甲氧基)乙基]腺嘌呤(PMEA)的类似物。溶液中异构络合物平衡定量的一个实例。
Inorg Chem. 2005 Jul 11;44(14):5104-17. doi: 10.1021/ic050341j.
7
Metal ion complexes of antivirally active nucleotide analogues. Conclusions regarding their biological action.抗病毒活性核苷酸类似物的金属离子络合物。关于其生物学作用的结论。
Chem Soc Rev. 2004 Mar 30;33(3):191-200. doi: 10.1039/b310349h. Epub 2004 Feb 10.
8
Intramolecular stacking interactions in ternary copper(II) complexes formed by a heteroaromatic amine and 9-[2-(2-phosphonoethoxy)ethyl]adenine, a relative of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl]adenine.由杂环芳胺与9-[2-(2-膦酰基乙氧基)乙基]腺嘌呤(抗病毒核苷酸类似物9-[2-(膦酰基甲氧基)乙基]腺嘌呤的类似物)形成的三元铜(II)配合物中的分子内堆积相互作用。
J Inorg Biochem. 2004 Dec;98(12):2114-24. doi: 10.1016/j.jinorgbio.2004.08.001.
9
Nickel(II), copper(II) and zinc(II) complexes of 9-[2- (phosphonomethoxy)ethyl]-8-azaadenine (9,8aPMEA), the 8-aza derivative of the antiviral nucleotide analogue 9-[2-(phosphonomethoxy)ethyl] adenine (PMEA). Quantification of four isomeric species in aqueous solution.9-[2-(膦酰甲氧基)乙基]-8-氮杂腺嘌呤(9,8aPMEA)的镍(II)、铜(II)和锌(II)配合物,9-[2-(膦酰甲氧基)乙基]腺嘌呤(PMEA)的抗病毒核苷酸类似物的8-氮杂衍生物。水溶液中四种异构体的定量分析。
Bioinorg Chem Appl. 2004;2(3-4):331-52. doi: 10.1155/S1565363304000202.
10
Complex formation of cadmium with sugar residues, nucleobases, phosphates, nucleotides, and nucleic acids.镉与糖残基、核碱基、磷酸盐、核苷酸及核酸的络合物形成。
Met Ions Life Sci. 2013;11:191-274. doi: 10.1007/978-94-007-5179-8_8.

引用本文的文献

1
Propentofylline Improves Thiol-Based Antioxidant Defenses and Limits Lipid Peroxidation following Gliotoxic Injury in the Rat Brainstem.丙戊茶碱可改善大鼠脑干神经毒性损伤后基于硫醇的抗氧化防御并限制脂质过氧化。
Biomedicines. 2023 Jun 7;11(6):1652. doi: 10.3390/biomedicines11061652.
2
Platinum-Nucleos(t)ide Compounds as Possible Antimetabolites for Antitumor/Antiviral Therapy: Properties and Perspectives.铂-核苷(t)化合物作为抗肿瘤/抗病毒治疗的潜在抗代谢物:性质与前景
Pharmaceutics. 2023 Mar 14;15(3):941. doi: 10.3390/pharmaceutics15030941.

本文引用的文献

1
Stopping pandemics before they start: Lessons learned from SARS-CoV-2.在疫情爆发前就阻止它们:从 SARS-CoV-2 中吸取的教训。
Science. 2022 Mar 11;375(6585):1133-1139. doi: 10.1126/science.abn1900. Epub 2022 Mar 10.
2
Molecular crowding and RNA catalysis.分子拥挤与RNA催化。
Org Biomol Chem. 2020 Oct 14;18(39):7724-7739. doi: 10.1039/d0ob01695k.
3
Visualizing group II intron dynamics between the first and second steps of splicing.可视化剪接第一和第二步之间的组 II 内含子动力学。
Nat Commun. 2020 Jun 5;11(1):2837. doi: 10.1038/s41467-020-16741-4.
4
Optimal molecular crowding accelerates group II intron folding and maximizes catalysis.最佳分子拥挤加速了第二类内含子的折叠并最大化了催化效率。
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):11917-11922. doi: 10.1073/pnas.1806685115. Epub 2018 Nov 5.
5
Divalent metal ions control activity and inhibition of protein kinases.二价金属离子控制蛋白激酶的活性和抑制作用。
Metallomics. 2017 Nov 15;9(11):1576-1584. doi: 10.1039/c7mt00204a.
6
Complex Formation of Lead(II) with Nucleotides and Their Constituents.铅(II)与核苷酸及其成分的络合物形成
Met Ions Life Sci. 2017 Apr 10;17. doi: 10.1515/9783110434330-011.
7
The structure of a nucleolytic ribozyme that employs a catalytic metal ion.一种利用催化金属离子的核酸裂解核酶的结构。
Nat Chem Biol. 2017 May;13(5):508-513. doi: 10.1038/nchembio.2333. Epub 2017 Mar 6.
8
A New View into the Regulation of Purine Metabolism: The Purinosome.嘌呤代谢调控的新视角:嘌呤体
Trends Biochem Sci. 2017 Feb;42(2):141-154. doi: 10.1016/j.tibs.2016.09.009. Epub 2016 Oct 28.
9
Approved Antiviral Drugs over the Past 50 Years.过去50年中获批的抗病毒药物。
Clin Microbiol Rev. 2016 Jul;29(3):695-747. doi: 10.1128/CMR.00102-15.
10
Catalytic metal ions and enzymatic processing of DNA and RNA.催化金属离子与 DNA 和 RNA 的酶促加工。
Acc Chem Res. 2015 Feb 17;48(2):220-8. doi: 10.1021/ar500314j. Epub 2015 Jan 15.